Sarah Simon Jackson, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Biliary Tract Neoplasms | 5 | 2021 | 185 | 2.410 |
Why?
|
Gallbladder Neoplasms | 5 | 2022 | 189 | 1.830 |
Why?
|
Cross Infection | 9 | 2019 | 1422 | 1.290 |
Why?
|
Transsexualism | 2 | 2023 | 208 | 1.230 |
Why?
|
Gallstones | 3 | 2024 | 284 | 1.050 |
Why?
|
Gram-Positive Bacterial Infections | 2 | 2018 | 342 | 1.020 |
Why?
|
Risk Adjustment | 4 | 2018 | 599 | 0.980 |
Why?
|
Common Bile Duct Neoplasms | 3 | 2022 | 120 | 0.980 |
Why?
|
Neoplasms | 9 | 2024 | 22131 | 0.930 |
Why?
|
Gender Identity | 3 | 2024 | 765 | 0.880 |
Why?
|
Ampulla of Vater | 3 | 2022 | 149 | 0.830 |
Why?
|
Neoplasms, Complex and Mixed | 1 | 2022 | 35 | 0.780 |
Why?
|
Sesamoid Bones | 1 | 2021 | 14 | 0.770 |
Why?
|
Protective Clothing | 2 | 2019 | 103 | 0.760 |
Why?
|
Hallux | 1 | 2021 | 43 | 0.740 |
Why?
|
Chemokine CCL20 | 1 | 2021 | 64 | 0.730 |
Why?
|
Skiing | 1 | 2020 | 25 | 0.710 |
Why?
|
Gloves, Protective | 3 | 2018 | 23 | 0.710 |
Why?
|
Dancing | 1 | 2021 | 104 | 0.690 |
Why?
|
Sprains and Strains | 1 | 2020 | 75 | 0.690 |
Why?
|
Aspirin | 3 | 2021 | 3127 | 0.690 |
Why?
|
Anger | 1 | 2022 | 406 | 0.680 |
Why?
|
Hormone Replacement Therapy | 2 | 2024 | 750 | 0.680 |
Why?
|
Chemokine CXCL10 | 1 | 2021 | 309 | 0.670 |
Why?
|
Sexual Behavior | 3 | 2024 | 2187 | 0.670 |
Why?
|
Cholangiocarcinoma | 2 | 2022 | 552 | 0.660 |
Why?
|
Interleukins | 4 | 2023 | 783 | 0.650 |
Why?
|
Platelet-Rich Plasma | 1 | 2021 | 178 | 0.630 |
Why?
|
Musculoskeletal System | 1 | 2021 | 188 | 0.620 |
Why?
|
Comorbidity | 6 | 2019 | 10505 | 0.620 |
Why?
|
Surgical Wound Infection | 3 | 2021 | 1529 | 0.600 |
Why?
|
Bacterial Load | 1 | 2018 | 151 | 0.600 |
Why?
|
Interleukin-8 | 1 | 2021 | 696 | 0.590 |
Why?
|
Enterococcus faecium | 1 | 2018 | 101 | 0.590 |
Why?
|
Catheter-Related Infections | 2 | 2017 | 273 | 0.570 |
Why?
|
Enterococcus faecalis | 1 | 2018 | 245 | 0.560 |
Why?
|
Running | 1 | 2021 | 488 | 0.540 |
Why?
|
Homes for the Aged | 1 | 2019 | 273 | 0.540 |
Why?
|
Hepacivirus | 3 | 2019 | 1330 | 0.520 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2018 | 250 | 0.510 |
Why?
|
Reproduction | 1 | 2020 | 645 | 0.510 |
Why?
|
Catheterization, Central Venous | 2 | 2017 | 526 | 0.500 |
Why?
|
Physical Examination | 1 | 2021 | 1254 | 0.480 |
Why?
|
Data Collection | 1 | 2024 | 3315 | 0.470 |
Why?
|
Anthropometry | 1 | 2019 | 1338 | 0.470 |
Why?
|
Hepatitis C, Chronic | 2 | 2019 | 1018 | 0.460 |
Why?
|
Organ Transplantation | 1 | 2024 | 1157 | 0.440 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2021 | 2270 | 0.430 |
Why?
|
Baseball | 1 | 2014 | 95 | 0.420 |
Why?
|
Cholera Vaccines | 1 | 2015 | 262 | 0.410 |
Why?
|
Early Detection of Cancer | 2 | 2024 | 3196 | 0.410 |
Why?
|
Equipment Contamination | 3 | 2018 | 182 | 0.400 |
Why?
|
Papillomavirus Infections | 1 | 2024 | 1611 | 0.400 |
Why?
|
England | 2 | 2024 | 526 | 0.400 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 697 | 0.400 |
Why?
|
Sex Factors | 8 | 2024 | 10548 | 0.380 |
Why?
|
Health Personnel | 4 | 2019 | 3333 | 0.370 |
Why?
|
Nursing Homes | 1 | 2019 | 1083 | 0.370 |
Why?
|
Maryland | 4 | 2019 | 277 | 0.370 |
Why?
|
Interleukin-6 | 1 | 2021 | 3206 | 0.360 |
Why?
|
Staphylococcal Infections | 1 | 2019 | 1406 | 0.340 |
Why?
|
Upper Extremity | 1 | 2014 | 658 | 0.320 |
Why?
|
Humans | 55 | 2024 | 760617 | 0.320 |
Why?
|
Cholera | 1 | 2015 | 747 | 0.320 |
Why?
|
Alleles | 2 | 2019 | 6861 | 0.320 |
Why?
|
Liver Cirrhosis | 1 | 2019 | 1926 | 0.310 |
Why?
|
Decision Support Techniques | 1 | 2019 | 1998 | 0.310 |
Why?
|
Risk Factors | 16 | 2024 | 74115 | 0.310 |
Why?
|
Ultrasonography | 4 | 2024 | 5964 | 0.300 |
Why?
|
Female | 32 | 2024 | 392148 | 0.280 |
Why?
|
Mood Disorders | 1 | 2013 | 1127 | 0.280 |
Why?
|
Acinetobacter baumannii | 2 | 2018 | 117 | 0.270 |
Why?
|
Minority Groups | 2 | 2023 | 1202 | 0.260 |
Why?
|
Male | 29 | 2024 | 360358 | 0.260 |
Why?
|
Incidence | 6 | 2024 | 21337 | 0.250 |
Why?
|
Hip Joint | 3 | 2024 | 1014 | 0.240 |
Why?
|
Muscle, Skeletal | 1 | 2020 | 4947 | 0.240 |
Why?
|
Bile Duct Neoplasms | 2 | 2021 | 605 | 0.240 |
Why?
|
Genetic Variation | 2 | 2019 | 6561 | 0.240 |
Why?
|
Adenocarcinoma | 1 | 2022 | 6340 | 0.240 |
Why?
|
Menopause | 2 | 2024 | 1645 | 0.240 |
Why?
|
Venous Thrombosis | 1 | 2014 | 1303 | 0.230 |
Why?
|
Aged | 20 | 2024 | 169042 | 0.230 |
Why?
|
Registries | 1 | 2020 | 8207 | 0.230 |
Why?
|
Middle Aged | 22 | 2024 | 220584 | 0.220 |
Why?
|
Patient Education as Topic | 1 | 2013 | 2315 | 0.220 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2016 | 2223 | 0.220 |
Why?
|
Chile | 2 | 2021 | 256 | 0.220 |
Why?
|
Primary Health Care | 2 | 2023 | 4668 | 0.210 |
Why?
|
Adult | 19 | 2024 | 220969 | 0.200 |
Why?
|
Suppositories | 1 | 2022 | 16 | 0.200 |
Why?
|
Baltimore | 3 | 2018 | 231 | 0.200 |
Why?
|
Prospective Studies | 9 | 2024 | 54360 | 0.200 |
Why?
|
HIV Infections | 3 | 2023 | 17337 | 0.190 |
Why?
|
Risk Assessment | 2 | 2020 | 23972 | 0.190 |
Why?
|
Intensive Care Units | 4 | 2018 | 3742 | 0.190 |
Why?
|
Indians, South American | 1 | 2021 | 34 | 0.190 |
Why?
|
Kidney Transplantation | 1 | 2016 | 4236 | 0.180 |
Why?
|
Administration, Oral | 2 | 2022 | 4010 | 0.180 |
Why?
|
Acinetobacter Infections | 2 | 2018 | 72 | 0.170 |
Why?
|
Infection Control | 2 | 2018 | 982 | 0.170 |
Why?
|
Opportunistic Infections | 1 | 2023 | 376 | 0.170 |
Why?
|
Progestins | 1 | 2022 | 301 | 0.170 |
Why?
|
Administration, Topical | 1 | 2022 | 703 | 0.170 |
Why?
|
Sarcoma, Kaposi | 1 | 2023 | 374 | 0.170 |
Why?
|
Specimen Handling | 1 | 2024 | 701 | 0.170 |
Why?
|
Athletic Injuries | 2 | 2021 | 1216 | 0.170 |
Why?
|
Herpes Simplex | 1 | 2023 | 465 | 0.170 |
Why?
|
Gallbladder | 1 | 2021 | 308 | 0.160 |
Why?
|
Infectious Disease Transmission, Professional-to-Patient | 1 | 2018 | 33 | 0.160 |
Why?
|
Psychotic Disorders | 1 | 2013 | 3220 | 0.150 |
Why?
|
Age Factors | 5 | 2024 | 18381 | 0.150 |
Why?
|
Papillomaviridae | 1 | 2024 | 1117 | 0.150 |
Why?
|
Michigan | 1 | 2019 | 339 | 0.150 |
Why?
|
Hospitals | 4 | 2021 | 3877 | 0.150 |
Why?
|
Gonadal Steroid Hormones | 1 | 2022 | 702 | 0.150 |
Why?
|
Vancomycin Resistance | 1 | 2018 | 125 | 0.150 |
Why?
|
Femur Neck | 1 | 2019 | 314 | 0.150 |
Why?
|
Hip | 1 | 2019 | 255 | 0.150 |
Why?
|
Progesterone | 1 | 2022 | 742 | 0.140 |
Why?
|
Case-Control Studies | 3 | 2022 | 22148 | 0.140 |
Why?
|
Perineum | 1 | 2018 | 208 | 0.140 |
Why?
|
Morbidity | 1 | 2022 | 1750 | 0.140 |
Why?
|
Estrogen Replacement Therapy | 1 | 2024 | 1208 | 0.140 |
Why?
|
Proportional Hazards Models | 3 | 2022 | 12447 | 0.140 |
Why?
|
Cumulative Trauma Disorders | 1 | 2018 | 151 | 0.140 |
Why?
|
Infection Control Practitioners | 1 | 2016 | 12 | 0.140 |
Why?
|
Aged, 80 and over | 7 | 2024 | 58894 | 0.140 |
Why?
|
Odds Ratio | 2 | 2021 | 9643 | 0.140 |
Why?
|
Physical Therapy Modalities | 1 | 2020 | 530 | 0.140 |
Why?
|
Nutrition Surveys | 1 | 2024 | 1723 | 0.130 |
Why?
|
Cytomegalovirus Infections | 1 | 2023 | 828 | 0.130 |
Why?
|
Egypt | 1 | 2016 | 96 | 0.130 |
Why?
|
Arthralgia | 1 | 2020 | 461 | 0.130 |
Why?
|
Neoplasm Staging | 2 | 2021 | 11116 | 0.130 |
Why?
|
Firearms | 1 | 2023 | 626 | 0.130 |
Why?
|
Drug Combinations | 1 | 2022 | 2048 | 0.130 |
Why?
|
Health Services Needs and Demand | 1 | 2023 | 1400 | 0.130 |
Why?
|
Digestive System Surgical Procedures | 1 | 2021 | 571 | 0.130 |
Why?
|
Lymphoma | 1 | 2024 | 1899 | 0.120 |
Why?
|
Cross-Sectional Studies | 4 | 2024 | 26049 | 0.120 |
Why?
|
Estrogens | 1 | 2022 | 1521 | 0.120 |
Why?
|
United States | 7 | 2021 | 72272 | 0.120 |
Why?
|
International Classification of Diseases | 2 | 2018 | 909 | 0.110 |
Why?
|
Logistic Models | 3 | 2018 | 13245 | 0.110 |
Why?
|
Immunization Schedule | 1 | 2015 | 227 | 0.110 |
Why?
|
Vaccines, Attenuated | 1 | 2015 | 315 | 0.110 |
Why?
|
United States Department of Veterans Affairs | 1 | 2019 | 928 | 0.110 |
Why?
|
Athletes | 1 | 2021 | 1137 | 0.110 |
Why?
|
Rectum | 1 | 2018 | 891 | 0.110 |
Why?
|
Spouses | 1 | 2016 | 283 | 0.110 |
Why?
|
HIV-1 | 2 | 2023 | 6858 | 0.110 |
Why?
|
Sex Characteristics | 1 | 2024 | 2637 | 0.110 |
Why?
|
Probability | 1 | 2019 | 2475 | 0.110 |
Why?
|
Feasibility Studies | 1 | 2024 | 5239 | 0.100 |
Why?
|
Fracture Fixation, Internal | 1 | 2019 | 971 | 0.100 |
Why?
|
Femur | 1 | 2019 | 1307 | 0.100 |
Why?
|
Suicide | 1 | 2023 | 1601 | 0.100 |
Why?
|
Carrier State | 1 | 2016 | 522 | 0.100 |
Why?
|
Esophageal Neoplasms | 1 | 2022 | 1653 | 0.100 |
Why?
|
Interferon-gamma | 1 | 2020 | 3145 | 0.100 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2024 | 2020 | 0.100 |
Why?
|
Feces | 1 | 2018 | 1490 | 0.100 |
Why?
|
Joint Instability | 1 | 2019 | 801 | 0.100 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2020 | 3514 | 0.100 |
Why?
|
Genetic Association Studies | 1 | 2021 | 2734 | 0.090 |
Why?
|
Health Status Disparities | 1 | 2023 | 1846 | 0.090 |
Why?
|
Pseudomonas Infections | 1 | 2016 | 621 | 0.090 |
Why?
|
Environmental Monitoring | 1 | 2018 | 1460 | 0.090 |
Why?
|
Cohort Studies | 7 | 2023 | 41457 | 0.090 |
Why?
|
Hip Fractures | 1 | 2019 | 988 | 0.090 |
Why?
|
Clostridium Infections | 1 | 2018 | 557 | 0.090 |
Why?
|
Pilot Projects | 1 | 2024 | 8618 | 0.090 |
Why?
|
Medical Records | 1 | 2016 | 1407 | 0.090 |
Why?
|
Bile Ducts, Extrahepatic | 2 | 2021 | 49 | 0.090 |
Why?
|
Lower Extremity | 1 | 2018 | 1200 | 0.090 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3194 | 0.090 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2019 | 1894 | 0.090 |
Why?
|
Young Adult | 6 | 2024 | 59179 | 0.090 |
Why?
|
Viral Load | 1 | 2019 | 3325 | 0.080 |
Why?
|
Antibodies, Bacterial | 1 | 2015 | 1463 | 0.080 |
Why?
|
Travel | 1 | 2015 | 796 | 0.080 |
Why?
|
Bile Ducts, Intrahepatic | 2 | 2021 | 296 | 0.080 |
Why?
|
Vibrio cholerae | 1 | 2015 | 793 | 0.080 |
Why?
|
Retrospective Studies | 7 | 2021 | 80566 | 0.080 |
Why?
|
Socioeconomic Factors | 2 | 2021 | 7798 | 0.080 |
Why?
|
Biomedical Research | 1 | 2024 | 3426 | 0.080 |
Why?
|
Pseudomonas aeruginosa | 1 | 2016 | 1272 | 0.070 |
Why?
|
Longitudinal Studies | 2 | 2021 | 14591 | 0.070 |
Why?
|
Risk Reduction Behavior | 1 | 2013 | 1110 | 0.070 |
Why?
|
Adolescent | 5 | 2024 | 88234 | 0.070 |
Why?
|
Survival Analysis | 1 | 2019 | 10073 | 0.070 |
Why?
|
Alcohol Drinking | 1 | 2019 | 4025 | 0.070 |
Why?
|
Prevalence | 1 | 2023 | 15689 | 0.070 |
Why?
|
Survival Rate | 1 | 2020 | 12719 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 3244 | 0.060 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2756 | 0.060 |
Why?
|
Electronic Health Records | 2 | 2019 | 4803 | 0.060 |
Why?
|
Range of Motion, Articular | 2 | 2024 | 1587 | 0.060 |
Why?
|
Obesity | 2 | 2023 | 12933 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5332 | 0.050 |
Why?
|
Smoking | 1 | 2019 | 9050 | 0.050 |
Why?
|
Anti-HIV Agents | 1 | 2019 | 4524 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3088 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3209 | 0.050 |
Why?
|
Medicare | 1 | 2021 | 6765 | 0.050 |
Why?
|
Body Mass Index | 2 | 2018 | 12943 | 0.050 |
Why?
|
Health Behavior | 1 | 2013 | 2643 | 0.050 |
Why?
|
Inflammation | 1 | 2021 | 10760 | 0.050 |
Why?
|
Homicide | 1 | 2023 | 294 | 0.040 |
Why?
|
Body Weights and Measures | 1 | 2021 | 208 | 0.040 |
Why?
|
Genome-Wide Association Study | 1 | 2019 | 12661 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 7995 | 0.040 |
Why?
|
Child | 3 | 2024 | 80079 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17878 | 0.040 |
Why?
|
Tooth Loss | 1 | 2021 | 200 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39063 | 0.040 |
Why?
|
Anticoagulants | 1 | 2014 | 4785 | 0.040 |
Why?
|
Time Factors | 1 | 2020 | 39913 | 0.040 |
Why?
|
Zambia | 1 | 2019 | 262 | 0.040 |
Why?
|
Hepatitis | 1 | 2019 | 228 | 0.040 |
Why?
|
Patients' Rooms | 1 | 2018 | 62 | 0.040 |
Why?
|
Receptors, CCR5 | 1 | 2019 | 486 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2019 | 15612 | 0.040 |
Why?
|
Knee | 1 | 2018 | 279 | 0.030 |
Why?
|
Longevity | 1 | 2024 | 1064 | 0.030 |
Why?
|
Genotype | 2 | 2023 | 12978 | 0.030 |
Why?
|
Interferons | 1 | 2020 | 703 | 0.030 |
Why?
|
Hospitals, University | 1 | 2018 | 564 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2019 | 64568 | 0.030 |
Why?
|
Organ Size | 1 | 2019 | 2252 | 0.030 |
Why?
|
Muscle Strength | 1 | 2018 | 624 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2019 | 2925 | 0.030 |
Why?
|
Specialization | 1 | 2018 | 778 | 0.030 |
Why?
|
Drug Resistance, Viral | 1 | 2019 | 861 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2018 | 12043 | 0.030 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2017 | 585 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 36402 | 0.030 |
Why?
|
Colon | 1 | 2021 | 1791 | 0.030 |
Why?
|
Gene Frequency | 1 | 2019 | 3601 | 0.030 |
Why?
|
CD4 Lymphocyte Count | 1 | 2019 | 2567 | 0.030 |
Why?
|
World Health Organization | 1 | 2018 | 1321 | 0.030 |
Why?
|
Virus Replication | 1 | 2020 | 2427 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2021 | 1884 | 0.020 |
Why?
|
Pandemics | 2 | 2023 | 8645 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2023 | 15908 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2019 | 1880 | 0.020 |
Why?
|
Bacteremia | 1 | 2017 | 977 | 0.020 |
Why?
|
Carcinoma | 1 | 2021 | 2327 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2018 | 2218 | 0.020 |
Why?
|
Anti-Bacterial Agents | 2 | 2018 | 7402 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2020 | 3045 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2024 | 20074 | 0.020 |
Why?
|
Blood Pressure | 1 | 2021 | 8472 | 0.020 |
Why?
|
Research Design | 1 | 2021 | 6174 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2024 | 26180 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 4007 | 0.010 |
Why?
|
Infant | 1 | 2024 | 36152 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5835 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 7960 | 0.010 |
Why?
|
Lung | 1 | 2020 | 9998 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16571 | 0.010 |
Why?
|
Child, Preschool | 1 | 2024 | 42188 | 0.010 |
Why?
|
Prognosis | 1 | 2021 | 29600 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7389 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15498 | 0.010 |
Why?
|